Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

99861

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the basis is for the distinction between Stage 1 and Stage 2 of hepatitis C virus which determines the amount of support sufferers of the condition who contracted the virus following NHS treatment with blood products are entitled to; and what medical and expert advice his Department sought before establishing this distinction.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	211083
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>The decision that there should be a two-stage ex-gratia payment system was taken when the scheme was first established in 2003-04. An initial ‘stage 1’ lump sum payment was made in respect of chronic infection with hepatitis C, with a second ‘stage 2’ lump sum payment when people reached a more advanced stage of illness. The Department sought the advice of an independent group of experts regarding a medical trigger for the higher payment that could reliably be diagnosed with non-invasive tests that were available nationwide. The advice received was that the second lump sum payment should be triggered following a diagnosis of cirrhosis or liver cancer, or if a person had received a liver transplant.</p><p> </p><p> </p><p> </p><p>In addition, as a result of the 2010 expert review, a further condition was added to those conditions that triggered eligibility for the second stage payment, namely hepatitis C-associated B-cell non-Hodgkins Lymphoma.</p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 17:11:03 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson

99870

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many (a) first-stage payments and (b) second-stage payments have been made from the Skipton Fund to the estates of individuals who contracted Hepatitis C following NHS treatment with blood products between 1970 and 1995 but who died after 29 August 2003.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	211079
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>The following table sets out the number of Stage 1 and Stage 2 payments made to the estates of individuals infected with hepatitis C through treatment with National Health Service supplied blood or blood products and who died after 29 August 2003 and before the relevant payment was made.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p>Stage 1</p></td><td><p>Stage 2</p></td></tr><tr><td><p>Total number of individuals</p></td><td><p>138</p></td><td><p>186</p></td></tr><tr><td><p>Comprising individuals with a bleeding disorder treated with plasma derived products</p></td><td><p>46</p></td><td><p>77</p></td></tr><tr><td><p>And individuals treated with a whole blood transfusion</p></td><td><p>92</p></td><td><p>109</p></td></tr></tbody></table><p> </p><p><em>Notes:</em></p><p> </p><p>The Stage 2 payment is made for individuals who received a stage 1 payment and progressed to more severe hepatitis C related disease.</p><p> </p><p><strong> </strong></p><p> </p><p>The number of Stage 2 payments to estates is greater than the number of Stage 1 payments to estates as some individuals who were alive on receipt of their Stage 1 payment (and so are not included in the stage 1 column in the table above) died before their Stage 2 payment was made.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 17:15:14 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson

99871

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what progress the Haemophilia Alliance has made in revising the National Service Specification for bleeding disorders.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	211076
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>NHS England has published the service specification for haemophilia services in England which was developed by and is regularly reviewed by the Haemophilia Clinical Reference Group (CRG). The CRG is also engaged in policy development with NHS England.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 17:14:46 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson

99872

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans he has to make provisions for counselling for those who contracted HIV and hepatitis C following treatment with NHS-supplied blood products and their families and dependants beyond the 2013-14 financial year.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	211036
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>In 2011, the Department set up a dedicated counselling service for people in England who were infected with HIV and hepatitis C infection as a result of treatment with NHS-supplied blood and blood products, and their families. The service has been extended to April 2016.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 17:22:23 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson

99873

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Haemophilia Society
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans he has to continue payments of £100,000 annually to the Haemophilia Society beyond 2014-15.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	211032
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>The Haemophilia Society is not currently in receipt of a grant from the Department. The final payment of £100,000 of the Haemophilia Society’s previous grant was made in the 2013-14 financial year.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 17:33:16 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson

99885

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 28 November 2012 to Question 129961, how many sufferers of bleeding disorders who received contaminated blood are in receipt of ex gratia packages; and what estimate he has made of the number who are eligible for such a package.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	211183
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>As at 22 October 2014, there are 532 individuals with bleeding disorders in receipt of at least one regular non-discretionary ex-gratia payment from MFET Ltd or Skipton Fund Ltd, for their HIV or Hepatitis C infection respectively. The Department has not made an estimate of those eligible for regular non-discretionary ex-gratia payments who have not to date applied for such payments.</p><p> </p><p> </p><p> </p><p>In addition, any individual with a bleeding disorder infected with HIV and in receipt of a regular payment from MFET Ltd is eligible to apply for discretionary support from the Macfarlane Trust. Any individual infected with only Hepatitis C who has received either a stage 1 or stage 2 payment from the Skipton Fund Ltd is eligible for discretionary support from the Caxton Foundation. There is also a range of other support for all such individuals, including counselling and cover for the cost of a Prescription Pre-payment Certificate.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 17:06:34 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson

99924

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people who contracted HIV and hepatitis C following treatment with NHS-supplied blood products signed waivers renouncing their rights to press charges against the Department for Health in the 1980s and 1990s; and how many such individuals are alive.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	211081
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>In 1988 a group of haemophilia patients infected with HIV brought litigation which was settled out of court for £42 million in 1991. A total of 1,437 people received payments from the settlement and a further 93 non-haemophilia patients infected with HIV later received equivalent payments to those made under the settlement. As a condition of receiving payments, these people were required to sign waivers stating that they would not bring any further proceedings against the Department of Health, the Welsh Office, the Licensing Authority, any District or Regional Health Authority, or any other Government body involving allegations concerning the spread of the HIV or hepatitis viruses through Factor VIII or IX (whether cryoprecipitate or concentrate), prior to 13 December 1990. It is not known how many of these people are still alive.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 17:26:36 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson

99947

registered interest
date	20/10/2014
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Blood: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, whether any savings an individual has accrued as a result of saving and investing lump-sum payments they have received from the Macfarlane and Eileen Trust, Macfarlane Trust, Eileen Trust or Skipton Fund are taken into account when deciding their eligibility for employment and support allowance and other welfare benefits; and whether the transfer of such savings to a dependant or partner, affects that dependant or partner's entitlement to benefits.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	211082
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p /> <p>Payments received from Government funded Trusts and Funds may be disregarded for benefit purposes. This includes payments from the following Trusts/Funds: Macfarlane, Eileen Trust and Skipton Fund.</p><p> </p><p>Any capital resource which derives from a payment from these Trusts/Funds, such as interest, is also disregarded indefinitely.</p><p> </p><p>Money which derives from the Trusts/Funds which is transferred to a partner is disregarded indefinitely in any benefit claim made by the couple. It is also disregarded indefinitely in any claim made by the partner after the sufferer’s death providing that the couple were not estranged or divorced at the time of the death. However, money derived from the Trusts/Funds which is transferred to a dependent child or young person is not disregarded in any subsequent claim made in later life by that person.</p> answering member constituency Forest of Dean answering member printed Mr Mark Harper question first answered 27/10/2014 17:55:45 answering member 1520 label Biography information for Mr Mark Harper
tabling member	1533 label Biography information for Dame Diana Johnson